News | March 17, 2023
Mindset Pharma to defend against lawsuit filed by Reunion Neurosciences
Mindset disagrees with and denies the allegations set forth from Reunion.
Mindset disagrees with and denies the allegations set forth from Reunion.
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Biocorp will receive an initial milestone payment this year
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Proposed combination enhances Pfizer’s position as a leading company in oncology
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The company will be submitting the responses to US FDA observations within stipulated timeline
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Subscribe To Our Newsletter & Stay Updated
